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Summary 
Mice  with a genetically engineered deficiency for either IL-4 or IFN-',/R1  (single  mutants), 
and IL-4/IFN-'yR1 (double mutants) on the Balb/c and 129Sv background were used to study 
the course of infection with Leishmania  major.  In contrast to genetically resistant  129Sv wild- 
type mice, IL-4/IFN-yR1 double mutant mice developed fatal disease with parasite dissemina- 
tion to visceral organs similar to mice lacking IFN-',/R1 only. Balb/c mice, which are exquis- 
itely susceptible to L. major, were rendered resistant to infection by disruption of the IL-4 gene. 
As compared to homozygous IL-4  +/+ mice, heterozygous IL-4  +/- animals consistently devel- 
oped smaller lesions with less ulceration and necrosis, indicating the likelihood of gene-dosage 
effects. This implicates that the magnitude of the IL-4 response determines the severity of dis- 
ease.  CD4 + T  cells of IL-4-deficient mice showed impaired Th2 cell development, as assessed 
by quantitative RT-PCR of characteristic cytokines. Development of resistance is not explained 
by default Thl  development, because this was observed only at very late stages of infection. 
Moreover, the induction  of inflammatory cytokines  (e.g.,  IL-I(x, IL-113, TNF-cr  IL-12)  to- 
gether with iNOS in the lesion and draining lymph nodes was not altered in the absence of IL-4. 
C 
utaneous infection of mice with Leishmania  major is a 
well-established  experimental  model  of chronic  hu- 
man disease  caused by an intracellular parasite (1).  The in- 
fection  of mice  of different  genetic  backgrounds  with  L. 
major results in one of two contrasting patterns of disease. 
In Balb/c and a few other mouse strains,  local infection is 
not effectively controlled by the immune response and the 
disease disseminates to involve visceral organs with eventu- 
ally  fatal  outcome.  Infection  of most  other  strains  (e.g., 
C57B1/6,  C3H/HeN,  129Sv)  causes a localized lesion that 
heals spontaneously after a few weeks. The resolution of le- 
sions is accompanied by the  development of complete re- 
sistance  to  reinfection.  MHC  class  II-restricted CD4 +  T 
cells are of critical importance for the development of clin- 
ical disease  (2-5)  , whereas MHC class I-restricted CD8 + 
T  cells  are of minor importance during primary infection 
(6).  Cure  and exacerbation of infection with L.  major has 
become a paradigm of the role of different T  helper subsets 
during  the  infection.  Resistant  strains  develop  predomi- 
nantly Thl  responses, as revealed by high levels of IFN-'y 
but undetectable IL-4. Susceptible strains develop predom- 
inantly Th2 responses, characterized by high levels of IL-4 
and strong antibody production  (7,  8).  Depletion of IL-4 
by neutralization  with mAb makes susceptible mice resis- 
tant (9-11) and depletion of IFN-'y by either mAb neutral- 
ization or gene disruption renders resistant mice susceptible 
to  infection  (12-14).  Neutralization  of IL-12,  a  cytokine 
promoting Thl  and suppressing Th2  development,  abro- 
gates resistance, whereas the supplementation of rlL-12 to 
susceptible mice allows them to resolve infection  (15-17). 
Moreover, resistant mice with an IL-4 transgene expressed 
at low levels in B cells fail to clear infection (18). Almost all 
of these immune interventions that change the disease  phe- 
notype have been shown to be associated with a switch in 
T  helper subset  development.  In this  article,  we  examine 
infection with L.  major in mice deficient for IL-4 and IFN- 
-/R1  on both a  genetically susceptible and resistant back- 
ground. 
Materials and Methods 
Mice, Parasites, and Infection.  Breeding  pairs  of homozygous 
IFN-'yRl-deficient  (IFN-',/R1 -/-)  and  control  IFN-',/R1 +/+ 
mice (129/Sv/Evans)(19)  were provided by M. Aguet (Genetech, 
San Francisco, CA). IFN-3,R1 -/- mice were bred with IL-4  -/- 
mice (129/Sv/Evans)  (20) to obtain IL-4/IFN-~/R1 double defi- 
cient mice. Mice were genotyped routinely by PCR of tail biop- 
sies. Primers used to distinguish the mutant and wild-type IL-4 
and  IFN-',/R1  loci  were  IL-4  for:  GTGAGCAGATGACAT- 
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~Rlfor:  AGATCCTACATACGAAACATACGG, IFN-~/Rlrev: 
TCATCATGGAAAGGAGGGATACAG, respectively.  IL-4-defi- 
cient mice (F2:129Sv ￿  C57B1/6) were backcrossed for six gen- 
erations  (F6)  onto  Balb/c  mice.  Heterozygous  IL-4  +/-  mice 
(Balb/c F6) were intercrossed to obtain the mice used for experi- 
ments.  Congenic  IL-4  -/- Balb/c  mice were  obtained by gene 
targeting in a Balb/c ES cell line as described (32). All mice were 
maintained under specific pathogen-free conditions in barrier fa- 
cilities  at  the  Max-Planck-lnstitute  for  Immunobiology 
(Freiburg, Germany). 8-15-wk-old mice of both sexes were used 
for infections and  housed in filter top  cages.  For some experi- 
ments blinded groups of mutant and wild-type Balb/c mice were 
sent to the Institute of Clinical Microbiology (University Erlan- 
gen) and infected there. The origin and propagation of the cloned 
virulent strain (MHOM/IL/81/FEBNI)  of L.  major has been de- 
scribed elsewhere (21).  Stationary phase promastigotes were col- 
lected from in  vitro culture in  biphasic Novy-Nicolle-McNeal 
(NNN) blood agar medium and, for infection, 2  ￿  106 parasites 
were injected subcutaneous into the right hind footpad. The clin- 
ical course developing after infection was monitored by measur- 
ing  the  footpad  swelling  with  a  metric  caliper  (Kroepelin, 
Schluchtern, Germany). 
Determination of Parasite Load.  For  quantitation  of  parasite 
number, a limiting dilution in vitro culture was performed essen- 
tially as described (22). Briefly, organs were homogenized and se- 
rial twofold dilutions were plated in three replicates at each dilu- 
tion in 96-well plates containing 50 I~1 NNN blood agar and 100 
~1  complete medium  (Click's RPMI,  supplemented with  10% 
FCS, 2 mM 1-Glutamine, 10 mM Hepes, 160 I~l/ml gentamycin, 
and  100  p,1/ml  penicillin (all from Biochem,  Berlin,  Germany) 
and 5 ￿  10 -5 M  2-ME. The plates were incubated at 28~  for 2 
wk and assessed for parasite growth microscopically. 
Collection of Lymph Nodes and Cell Separation.  For  analysis  of 
cytokine  production  and  transcripts,  popliteal  lymph  nodes 
(PLN)  were  excised at designated times,  teased to  a  single-cell 
suspension and CD4 + T  lymphocytes were purified by incuba- 
tion  with  magnetized  anti-CD4-antibodies using  the  MACS  | 
system  according  to  the  manufacturer's  instructions  (Miltenyi 
Biotech,  Bergisch  Gladbach,  Germany).  FACS  |  analysis  of the 
resulting CD4 §  cell population revealed >90% purity (data not 
shown). Cells were always kept at 4~  and collected before and 
after CD4 § selection for either RNA preparation or in vitro re- 
stimulation. 
Stimulation of Cells and Cytokine Production.  CD4 §  cells  were 
plated at a concentration of 4 ￿  105 per well (200 Ixl) in flat-bot- 
tomed  96-well tissue  culture plates and  stimulated with  solid- 
phase coupled anti-CD3 mAb 145-2Cli  (20 b~g/rnl) and rmlL-2 
(250  U/ml;  Genzyme,  Munich,  Germany).  Supernatants  were 
harvested after 48 h, pooled and stored at -20~  until used. Cy- 
tokine levels in the supernatants were determined by ELISA with 
paired monoclonal antibodies for IL-4, IL-5, IL-10, and IFN-'y 
(all from PharMingen, San Diego, CA). 
RT-PCR.  At designated times after infection,  total cellular 
RNA was prepared from homogenized tissue  (e.g., infected and 
contralateral uninfected footpad) and from PLN cells prepared as 
described  above  using  Trizol  TM  (GIBCO  BRL,  Gaithersburg, 
MD).  Random hexamer-primed reverse transcription (RT) was 
performed with Superscript-RT (GIBCO BRL) using 3 txg total 
RNA in a 30 Ixl reaction volume containing 0,04 u (1.2 ng) ran- 
dom hexamers  (Pharmacia, LKB,  Freiberg, Germany),  0.4  mM 
dNTP  (Promega,  Ziirich,  Switzerland)  50  mM  Tris-HC1,  pH 
8.3,  75  mM  KC1,  3  mM  MgC12, and  0.5  units  RNAsin 
(Promega).  After 90  min  of incubation  at  37~  samples were 
heated at 94~  and then quickly chilled on ice. Samples were di- 
luted  1:10  with  H20  to  a  concentration  of 10  ng/~l  cDNA 
equivalents assuming a 1:1 ratio of reverse transcription. Cycling 
conditions for all PCR amplifications of cytokines were 94~  for 
2 rain before 35 cycles of 94~  for 20 s, 58~  for 30 s, and 72~ 
for 30 s, followed by a final extension at 72~  for 5 rain. Cycling 
conditions for  the  amplification of ]32-microglobulin ([32-mgl) 
and hypoxanthin-phosphoribosyl-transferase (HPRT) consisted of 
30 and 32 cycles, respectively.  The templates for PCR consisted of 
2 to 4 p,1 of the diluted RT reaction. 
Construction of a PCR  MIMIC for the  Quantitative  Analysis  of 
Cytokine  Transcripts.  A  competitive PCR  MIMIC control vec- 
tor  (pNIL)  containing a  multispecific primer cassette  was  con- 
structed essentially as described (23) to enable quantitative analysis 
of IL-12p40,  IL-12p35,  IL-10,  IL-13, and iNOS  transcripts. A 
PCR MIMIC control vector, pMus (24), for the quantitation of 
IL-lci, lL-113, IL-2, IL-3, IL-4, IL-5, IL6, TNF-ci, IFN-'y, and 
]32-microglobulin transcripts was  kindly provided by D.  Shire, 
Sanofi,  Toulouse.  PMCQ,  a  MIMIC  control  vector for  LT~x 
(TNF-]3)  (25),  was  kindly provided by  T.  Blankenstein  (Max 
Delbrick Center,  Berlin).  Primer sequences  and  the  lengths  of 
amplified cDNA fragments and MIMIC controls are given in Ta- 
ble 1 below. Primers were designed to span introns. 
Quantitation of Cytokine  Transcripts.  The  level  of  individual 
transcripts was determined by competitive PCR as described (23, 
26)  using  the  multispecific MIMIC  control  vectors  described 
above. PCR reactions with equal aliquots (usually 4 I-U) of the di- 
luted RT-reaction containing approximately 40 ng cDNA equiv- 
alents and oligonucleotide specific primers were  added to  serial 
fourfold dilutions of known molarity (5 ￿  106 to 7.5  ￿  101 11101- 
ecules)  of the appropriate MIMIC plasmid. PCR  co-amplifica- 
tion was performed using the cycling conditions described above. 
Specific primers compete for annealing and amplification of the 
control fragment and cellular cDNA, resulting in fragments that 
differ 50-100  bp in size.  The  PCR  products derived from  the 
MIMIC template and the cDNA were resolved on an agarose gel, 
and the relative ethidium bromide staining intensities of the target 
and the MIMIC DNAs were compared. Equal band intensities of 
both fragments allow the  quantitation of eDNA relative to  the 
competitor. For numerical calculation, the ratio was formed be- 
tween the dilutions of the respective eDNA and competitor flag- 
ment. Before quantitation of individual transcripts, cDNAs were 
adjusted to equal concentrations of both ]32-microglobulin (]32- 
mgl) and HPRT. 
Results  and Discussion 
IFN-7 but not IL-4 Determines the Outcome of L.  major In- 
fection in Genetically Resistant Mice.  Mice  (129Sv)  deficient 
for either IL-4 (IL-4  -/-) or IFN-~/R1  (IFN-~/R1-/-), and 
(IL-4/IFN-'yR1) doubly deficient mice were infected with 
L.  major promastigotes subcutaneously in one hind footpad, 
and the clinical course of infection was monitored for up to 
9  wk.  Disease outcome with respect to the size of footpad 
lesion and parasite load is shown  in Fig.  1 A  and Table 2, 
respectively. In  the  absence  of an  intact  IFN-~/R1,  mice 
with  an  otherwise  resistant  genetic  background  (129Sv) 
were unable to control the growth of L.  major.  Already at 
day 24  after infection,  the number  of viable parasites was 
>5,000-fold  increased  in  the  draining  popliteal  lymph 
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Primer sequence 
Gene  5'  3'  5'  3'  cDNA  MIMIC 
~2-m~  ~r:  TGACCGGCTTGTATGCTATC 
IL-I~  ~r:  CAGTTCTGCCATTGACCATC 
IL-I~  ~r:  TTGACGGACCCCAAAAGATG 
IL-2  ~r:  GACACTTGTGCTCCTTGTCA 
IL-3  ~r:  GACCCTCTCTGAGGAATAAG 
IL-4  ~r:  TCGGCATTTTGAACGAGGTC 
IL-5  ~r:  TCACCGAGCTCTGTTGACAA 
IL-6  ~r:  GTTCTCTGGGAAATCGTGGA 
TNF-~  ~r:  TCTCATCAGTTCTATGGCCC 
IFN-~  ~r:  GCTCTGAGACAATGAACGCT 
TGF-~  ~r:  ACCGCAACAACGCCATCTAT 
TNF-~/LT-~  ~r:  GGGAACAGGGGAAGGTTGAC 
IL-10  ~r:  AGCCGGGAAGACAATAACTG 
IL-12p35  ~r:  GATGACATGGTGAAGAC  GGC  C 
IL-12p40  ~r:  CTGGCCAGTACACCTGCCAC 
IL-13  ~r:  CTCACTGGCTCTGGGCTTCA 
iNOS  ~r:  AGCTCCTCCCAGGACCACAC 
rev:  CAGTGTGAGCCAGGATATAG  222 
rev:  TCTCACTGAAACTCAGCCGT  218 
rev: AGAAGGTGCTCATGTCCTCA  204 
rev: TCAATTCTGTGGCCTGCTTG  227 
rev: CTCCAGATCGTTAAGGTGGA  232 
rev: GAAAAGCCCGAAAGAGTCTC  216 
rev: CCACACTTCTCTTTTTGGCG  201 
rev: TGTACTCCAGGTAGCTATGG  208 
rev: GGGAGTAGACAAGGTACAAC  212 
rev: AAAGAGATAATCTGGCTCTGC  227 
rev: GTAACGCCAGGAATTGTTGC  200 
rev: CTTTCTTCTAGAACCCCTTGG  205 
rev: CATTTCCGATAAGGCTTGG  189 
rev: GGAGGTTTCTGGCGCAGAGT  402 
rev: GTGCTTCCAACGCCAGTTCA  384 
rev: CTCATTAGAAGGGGCCGTGG  420 
rev:  ACGCTGAGTACCTCATTGGC  481 
320 
320 
320 
320 
320 
320 
320 
320 
320 
320 
320 
290 
280 
280 
220 
30O 
320 
nodes  of IFN-~/R1 -/-  compared to control wild-type mice. 
From week 6  to 8  after infection,  IFN-',/R1-/-  mice died 
with fulminant visceral leishmaniasis. Parasitized livers of these 
mice showed large areas of confluent inflammatory infiltrates 
consisting mainly of polymorphonuclear cells in necrotic liver 
parenchyma (Fig.  2  b).  Infection  of IFN-yR1/IL-4  doubly 
deficient  mice  resulted  in  fatal disease  (e.g.,  parasite  load, 
tissue  damage)  indistinguishable  from  IFN-~/R1 -/-  mice 
(Table  2,  Figs.  1 A  and  2  c),  whereas  IL-4 -/-  mice  con- 
trolled  the  infection  as  effectively as  the  129Sv  wild-type 
mice, which had only small foci of inflammatory infiltrates 
of mainly  mononuclear  cells  in  liver  tissue.  These  results 
confirm an essential role of IFN-'y/IFN-~/R1 for the elimi- 
nation of L. major (12,  13). In terms of the disease outcome 
in genetically resistant mice, the presence or absence of IL-4 
was inconsequential.  The absence oflL-4, in particular, did 
not  change  the  severity of disease  in  double-mutant  mice 
below that seen in single IFN-yR1  mutant animals.  These 
data are novel and would not have been predicted based on 
data  demonstrating  that  in  vivo neutralization  of IL-4 re- 
verses  the  exacerbative  effect  of neutralization  of IFN-~/ 
with monoclonal antibodies  (27). 
The Absence of lL-4  Confers Resistance to Infection with L. 
major in Susceptible Mice.  To study the influence of IL-4 in 
a genetically susceptible strain, the disrupted IL-4 locus was 
backcrossed  for  6  generations  (F6)  onto  Balb/c  mice.  As 
expected,  IL-4 competent  Balb/c  mice  infected  with  L. 
major developed progressive  disease,  as  assessed by parasite 
load  (Table  2),  footpad swelling  (Fig.  1  B),  ulceration  and 
necrosis of the lesion  (Fig.  2  e). In contrast,  IL-4 -/-  Balb/c 
mice  (F6)  were  resistant  to  progressive  infection  and  no 
signs of necrosis of the lesion were observed.  Interestingly, 
as  compared  to  homozygous  IL-4 +/+  mice,  heterozygous 
IL-4 +/-  (F6)  animals consistently developed smaller lesions 
(Fig.  1  B)  with less ulceration  and  necrosis,  indicating  the 
likelihood  of gene-dosage  effects.  A  correlation  between 
the  magnitude  of the  IL-4 response  and  of the  severity of 
disease  was  established  earlier  by  comparing  different  in- 
bred  strains  covering  the  range  of susceptibility  to  disease 
(28). Likewise, Balb/c  ￿  C57BL/6  F1  hybrid mice are in- 
termediate  in  the  severity of disease  compared  to  the  sus- 
ceptible  Balb/c  and  resistant  C57B1/6  parents  (29).  The 
fact that the F2 generation can be divided into three groups 
in  conformity with  a  1:2:1  ratio  suggests  that  genetic  sus- 
ceptibility  to  L.  major is under  the  control  of a  single  ge- 
netic locus.  While  the  exact location  of the  putative  resis- 
tance  gene(s)  is unknown,  there  is evidence  from linkage 
studies  that it maps with high concordance  to genes at the 
mid to the distal end of chromosome  11  (30,  31),  a region 
including the IL-4 gene family cluster and IL-12p40.  Con- 
sidering these results,  we could not exclude the  possibility 
that  the  resistance  of IL-4 -/-  Balb/c  mice  (F6)  is  influ- 
enced  by the  presence  of a  resistance  gene(s)  carried  over 
by breeding the mutant IL-4 locus from a resistant (129Sv) 
onto  a  susceptible  strain.  To  test  this  possibility,  we  fol- 
lowed L.  major infection in IL-4 -/-  Balb/c mice that were 
obtained from targeting in Balb/c ES  cells  (32). As shown 
in Fig.  1 b, these mice resisted infection comparable to IL- 
4 -/-  Balb/c  (F6)  backcrosses.  At  day  42  after  infection, 
when the acute inflammatory footpad swelling reaction de- 
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Figure 1.  Course of L. major  infection in [FN-2*-receptor 1 and IL-4-defi- 
cient mice.  Mice (5 per group)  were infected  in the hind footpad  with 
2 ￿  1@ promastigotes of L  major  and the course of disease monitored by 
using metric calipers to measure footpad swelling. Infected mice included 
genetically resistant mice deficient for IL-4  /-, IFN-ylL-:  , 1L-4/IFN- 
yR doublemutant,  and wild-type controls (all 129Sv)(A), and genetically 
susceptible Balb/c mice (IL-4 +/+) with a homozygous  (IL-4 -/-) or het- 
erozygous (IL-4 +/-) disruption of the IL-4 gene. The IL-4 mutation  was 
derived either in 129Sv ES cells and heterozygous mice were backcrossed 
for six generations to Balb/c (B/c F6) mice, or in Balb/c ES cells and het- 
erozygous mice backcrossed for two generations  to Balb/c mice (IL4 /- 
B/c). Resistant IL-4  -/- B/c mice were maintained for more than 5 mo. 1 
out of 5 mice developed progressive lesion size after 3 too. Representative 
results  (mean  +  SE)  from  one  of two  independent  experiments  are 
shown. * indicates death of individuals. 
clined,  histological  examination  revealed  typical  granula- 
tion tissue with proliferated fibroblasts,  collagen deposition 
and scar formation,  together,  indicating concomitant repair 
of the  lesion  (Fig.  2 f).  The  number  of viable parasites  in 
the draining popliteal lymph node (PLN)  oflL-4 -/-  Balb/c 
mice  was  32-fold  reduced  compared  to  Balb/c  wild-type 
controls.  However, parasite  elimination in  IL-4 -/-  Balb/c 
mice  was  not  as  efficient  as  in  genetically  resistant  129Sv 
mice. A  cohort of infected IL-4 -/- Balb/c mice was main- 
tained  for  more  than  5  mo,  confirming  their  capacity  to 
control  the infection for long periods.  In accordance  with 
previous studies that used mAbs to neutralize IL-4 in Balb/c 
mice,  this  finding  shows  that  a  null-mutation  of the  IL-4 
gene  confers  resistance  to  L.  major infection in  susceptible 
Table 2.  Parasite  Load in Lesions and Lymphoid  Tissues qf Mice 
Deficient for IL4 and~or IFN-TRI Infected with L. Major 
Strain 
Day 24  Day 42 
No.  PLN  spleen  footpad  PLN  spleen 
IL-4 wt  1  223  2"  22"  221  213 
Balb/c  2  222  211  222  221  2 > 
IL-4 ko  1  21~  29  2 >  2 Ir  2 ') 
Balb/c  2  2 is  2')  2 I"  21~  27 
wildtype  1  213  29  2 Ir  2 '~  24 
129  Sv  2  2 t~  2  a  217  2 I"  2 -~ 
IL-4 ko  1  215  27  2 Is  2 Ill  27 
129 Sv  2  ND  ND  ND  2 III  24 
IFNyR. ko  1  227  213  221  2 23  219 
129 Sv  2  2 2('  2"'  2 211  224  2 v) 
IFNyR/IL-4  1  231'  2 is  222  224  224 
doubly ko 
129 Sv  2  ND  ND  ND  224  2 I'~ 
Groups of mice (n =  5) were infected with 2 X 1if' L. major  promastig- 
otes into the right hind footpad.  The animals were killed at day 24 or 42 
and the parasite load was determined in spleens, popliteal  lymph nodes, 
and  footpads.  Serial  twofold  dilutions  of organ  homogenates  were 
plated in micro-titer plates and cultured for two weeks and assessed for 
parasite growth.  Shown are values of two representative  individuals  of 
each  group.  Numbers  indicate  the reciprocal  of dilution  in which  at 
least two out of three replicates were positive. 
mice.  However, by using the same strain of IL-4 -/- Balb/c 
mice to study the outcome of infection with L. major, other 
investigators  arrived  at  opposite  conclusions.  The  knock- 
outs remained susceptible  (33).  While we presently  do  not 
understand  the  reason  for  this  discrepancy,  it  should  be 
noted,  that  the  other  report  shows  that  both  parasitemia 
and  lesion  size  were  already  declining  in  IL-4 -/-  Balb/c 
mice, while they were still progressing in Balb/c wild-type 
controls at a later time point of infection (33). 
The Absence  of IL-4  in  Balb/c Mice Infected with  L.  major 
Impairs  Th2 Development without Preferential Expansion of Th I 
Development In  Vivo.  The  development  of either  protec- 
tive immunity or progressive disease after experimental in- 
fection of C57B1/6  and Balb/c mice with L. major has been 
clearly correlated with either the expansion  of Thl  or Th2 
cells,  respectively.  IL-4-deficient  mice have  impaired  Th2 
but enhanced  Thl  responses,  when infected with a  variety 
of pathogens  (20,  34-38).  The  developmental  pathway  of 
T  helper subsets in IL-4 -/-  and IL-4 +/+ Balb/c mice at day 
22 post infection with L.  major was determined by compet- 
itive  RT-PCR  of a  panel  of characteristic  Thl  and  Th2 
cytokines from both total popliteal lymph node (PLN)  cells 
and purified CD4 + PLN cells before and after restimulation 
with anti-CD3  (Fig. 3, Table 3).  In infected IL-4 +/+ Balb/c 
mice, both Th2 (e.g., IL-4, IL-10, IL-13) and Thl  cytokines 
(e.g.,  IFN-y,  TNF-[3)  were  strongly  elevated.  IL-5,  an- 
1130  Leishmaniasis  in IL-4- and IFN-yRl-deficient Mice Figure 2.  Histopathology of L. major  infected mice. At day 42 after infection, livers oflFN-"/Rl-deficient (b) and IFN-',/R_I/IL-4 doubly deficient (c) 
mice (129Sv) show large areas of confluent inflammatory infiltrates consisting mainly of polymorphonuclear  cells in necrotic liver parenchyma, whereas 
livers of  both genetically resistant 129Sv (a) and susceptible Balb/c wild-type mice (d) contain only small foci of  inflammatory infiltrates of mainly mono- 
nuclear cells. Footpads of Balb/c wild-type  mice (e) show ulceration and necrosis adjacent to acute inflammation of the dermal connective tissue with 
mainly polymorphonuclear infiltrates (e). In contrast, photographs of sectioned footpads oflL-4-/- Balb/c mice (f) reveal a chronic inflammatory re- 
action with granulation tissue containing  mononuclear inflammatory ceils, spindle shaped fibroblasts  and collageneous fibers indicating scar formation and 
concomitant repair of the lesion. Sections were prepared 6 wk after infection and stained with hematoxylin and eosin. Original magnification 50 ￿ 
other  Th2  cytokine,  was  poorly  expressed  after  infection. 
With  the  exception  of TNF-[3,  enhanced  transcriptional 
levels  of individual Thl  and  Th2  cytokines  were  found 
mainly in the CD4 + population, consistent with the MHC 
class  II/CD4 +  T  cell dependence  of the infection and the 
identification  of CD4 +  T  cells  as  the  primary  source  of 
these  cytokines  (8).  No  such  induction of Th2  cytokines 
was  observed  in  CD4 +  T  cells  of infected  IL-4  -/-  mice, 
which contained 8-16-fold lower levels oflL-10 and IL-13 
transcripts  (Fig.  3,  Table  3).  More  interestingly, levels  of 
1131  Kopfetal. Figure 3.  Cytokine mRNA expression 22 d after infection with g  ma- 
jor. Groups of  five IL-4-deficient (IL-4  -/- Balb/c F6) and control (IL-4  +/+ 
Balb/c  F6) mice were infected with L major. On day 22 post-infection 
popliteat lymph node cells were harvested, pooled, and CD4 + T cells iso- 
lated with anti-CD4 magnetic beads. The levels of the indicated cytokine 
mRNA transcripts  were determined by competitive RT-PCR after stan- 
dardization for the expression of the constitutively transcribed 182-micro- 
globulin gene. Constant amounts of cDNA samples  were amplified in the 
presence of serial fourfold dilutions of a multispecific internal plasmid 
control ranging from 5 ￿  10  6 to 7.5 X 101 molecules.  Competitor con- 
struct (mimic) and transcript ampticons were separaeed  in an agarose gel 
and visualized by ethidium  bromide  staining. Equal densities of target 
cDNA and competitor fragment were used to calculate  the ainount of  ini- 
tial target gene given by the molar amount of competitor plasmid used for 
amplification. All PCR results shown were repeated two to three times 
independently to confirm results. The figure represents one single dilu- 
tion taken from the titration to compare expression of the indicated cy- 
tokine in the different samples. The gel was photographed with a CCD 
high resolution video camera system (GDS 5000; UVP Cambrdige, UK) 
and  the  image  printed  using Adobe  Photoshop  TM  3.0. Lane  1,  non- 
IFN-'y transcripts were comparable in both groups of mice. 
To follow whether IL-12, a cytokine which promotes Thl 
development  and  hence  IFN-y  responses,  was  altered  in 
the absence of IL-4 we determined transcript levels of both 
chains of the  IL-12 heterodimer,  IL-12p40 and IL-12p35, 
at  day  22  post  infection.  IL-12  mRNA  levels were  very 
low in PLN,  with no  difference comparing wild-type and 
mutant mice. 
Further,  upon  stimulation  of PLN  CD4 +  T  cells from 
infected IL-4  +/+  mice with  anti-CD3  significant amounts 
of both  Thl  (e.g.,  IFN-2/) and Th2  cytokines (e.g.,  IL-4, 
IL-10) were secreted into supernatants (Fig. 4  a). Superna- 
tants  from  CD4 +  T  cells  of IL-4  -/-  mice  contained  re- 
duced levels of IL-10, which indicates reduced Th2  devel- 
opment,  whereas  levels  of  IFN-~/  were  comparable  to 
controls.  Elevated  (fourfold)  levels  of  IFN-~/  indicating 
Thl  default development in IL-4  -/- mice were found only 
at late stages of infection  (9 wk)  (Fig. 4  b), suggesting that 
Thl  default  development  is  not  responsible for  the  resis- 
tance of IL-4  -/-  mice. Hence,  IL-4  +/+  Balb/c mice exac- 
erbate infection despite the presence  of a powerful IFN-y 
response. This may explain why continuous administration 
of exogenous  IFN-y did not ameliorate L.  major infection 
in  Balb/c  mice  (9).  Indeed,  it  has  become  evident  from 
other studies that susceptible and resistant mice do not con- 
siderably differ in IFN-y levels or the number of IFN-y se- 
creting cells within the first 3  to 4  wk of infection  (6,  13). 
Mutually exclusive Th  responses have been observed only 
at very late stages of infection (4). Taken together, these re- 
sults clearly demonstrate that the key player in susceptibility 
to L.  major is IL-4: the more the worse. Balb/c mice do not 
develop fatal disease because  of a  loss of the  ability to  in- 
duce  IFN-',/responses, as suggested recently by elegant in 
vitro studies  (39),  but by their failure to downregulate the 
production of IL-4. 
The Absence of  lL-4 Has No Consequence on Transcript Levels of 
iNOS  IL-1,  TNF,  and  TGFol3  in  the  Lesion  and  Lymphoid 
Tissues of Infected Mice.  Macrophage activation and the subse- 
quent  production of pro-inflarmnatory cytokines (e.g., IL-1, 
TNF),  together  with  anti-microbial products  such  as  the 
radical nitric oxide (NO), has been suggested to be an im- 
portant  effector  pathway  in  Leishmania  defense  (40-43). 
IFN-~/  is  a  key  inducer  of  NO  production  (19,  44), 
whereas IL-4, IL-10, IL-13, and TGF-13 are inhibitory cy- 
tokines (45-50).  For instance,  neutralization of TGF-[3 al- 
lows  otherwise  susceptible  mice  to  resist  Leishmania  bra- 
ziliensis infection (51).  The activation state of macrophages 
and  their  defense  potential  were  studied  directly  in  the 
lesion  by  RT-PCR  amplification of a  panel  of pro-  and 
anti-inflammatory cytokines and the inducible nitric oxide 
synthase  (iNOS).  Infected  and  contralateral  uninfected 
footpads were removed at day 22 of infection, when the le- 
infected nfice; lanes 2-5,  infected mice. Lanes 1, 2, and 4, IL-4  +/+ Batb/c; 
lanes 3 and 5, IL-4  -/- Balb/c mice. Lanes 1-3, total PLN; lanes 4 and 5, 
CD4 + PLN T cells. M, DNA size marker. 
1132  Leishmaniasis in IL-4- and IFN-yRl-deficient Mice Table 3.  Quantification of Transcripts of a Variety of Cytokines in Popliteal Lymph Nodes of lL-4-deficient Mice on Day 22 after 
Infection with L. Major 
PLN (p. Lm)  CD4 + cells PLN (p. Lm)  CD4+  PLN (,p.Lm) <CD3 
PLN naive 
IL_4+/*  IL_4+/+  IL_4-/-  IL_4+/+  IL_4-/-  IL_4+/+  IL_4-/- 
IL-4  <0.16  1.22  <0.16  4.88  <0.16  39  <0.16 
IL-5  <0.16  nt  nt  0.61  <0.61  nt  nt 
IL-10  <0.16  0.61  0.16  2.44  0.32  4.88  0.61 
IL-13  <0.16  nt  nt  2.44  <0.16  9.76  0.61 
IFN-'y  <0.16  19.6  19.6  156.3  78.1  156.3  312.5 
TNF-J3  78.1  312.5  312.5  78.1  78.1  nt  nt 
TNF-ot  <0.64  9.76  9.76  9.76  9.76  nt  nt 
TGF-[3  <0.64  39.2  19.6  19.6  19.6  nt  nt 
IL-12p40  <0.16  0.61  0.61  <0.16  <0.16  nt  nt 
iNOS  nt  0.61  0.61  nt  nt  nt  nt 
Transcript levels were calculated using competitive RT-PCR as described in the legend to Fig. 3. Values represent the ratio of target gene: ]32-micro- 
globulin gene expression (￿  10-4). p.Lm, post L. major; infection; <CD3, after stimulation with anti-CD3;  nt, not tested. 
sion  size  in  IL-4  -/-  Balb/c  mice  (F6)  peaked and  differ- 
ences  in healing between  mutant  and wild-type mice be- 
came  first  evident.  Transcripts  encoding  IL-lo~,  IL-113, 
TNF-ot, TGF-I3, and iNOS were highly elevated in the in- 
fected  compared  to  noninfected  footpad  and  little differ- 
ences  were  detected  between  IL-4  +/+  and  IL-4  -/-  mice 
(not shown).  Similarly, we found no differences in the ex- 
pression ofTNF-ix, TGF-[3, and iNOS (Fig. 3, Table 3) in 
draining PLN  of both  groups  of mice.  It may have  been 
anticipated that the absence of IL-4 and a  concomitant re- 
duction of IL-10 and IL-13 results in elevated macrophage 
effector functions  such  as  increased NO  production  (47). 
Comparing resistant C57B1/6  mice and susceptible Balb/c 
mice, an inverse pattern of expression ofiNOS  and TGF-[3 
was  observed.  C57B1/6  mice  expressed  high  levels  of 
iNOS and low levels of TGF-[3 protein, whereas disease in 
Balb/c  mice  correlated with  low levels  of iNOS  and  in- 
creased TGF-[3 (52).  Our results show that the absence of 
IL-4 did neither increase the  mRNA  expression of iNOS 
nor  attenuate  the  expression  of  TGF-[3.  However,  as 
shown for both NO  and TGF-13, the regulation may occur 
posttranscriptionally (53)  (Steven Reed,  personal commu- 
nication).  On  the  other  hand,  the  detrimental  activity of 
IL-4 on macrophage function in susceptible Balb/c mice is 
possibly exerted  only during  the  first days  of infection  as 
suggested by the inability of anti-IL-4 treatment to support 
a  curative outcome  when  administered 7-14  days post in- 
fection  (10).  It  has  been  shown  previously that  infection 
with promastigotes induce  a  rapid biphasic IL-4 response, 
which is curtailed by IL-12, within the first hours and few 
days of infection. The first but not the second burst of IL-4 
is dependent on  IFN-%  (54-56).  This early IL-4 response 
may be decisive for the fatal outcome of infection, since it 
is mainly found in susceptible mice. It remains to be shown 
Figure  4.  Cytokine  produc- 
tion  of  CD4+  T  cells from 
popliteal lymph nodes of L. major 
infected mice at day 22 (a) or day 
63 (b). CD4+ T cells prepared as 
described in the legend to Fig. 3 
were restimulated with immobi- 
lized anti-CD3  for 48 h. Desig- 
nated cytokines in  the  supema- 
tants were  measured by ELISA 
using specific monoclonal  anti- 
bodies (all PharMingen). Values 
for IL-4 and IL-10 are given as 
ng/ml; for IFN-3' as U/ml. 
1133  Kopf et al. whether IL-12 and other macrophage functions are antago- 
nized by the early IL-4 response. 
As shown previously, IL-4  -/- mice are completely resis- 
tant to L. mexicana infection, a different species of Leishma- 
nia, which grow cutaneously and induce nonhealing  lesions 
in most strains of mice (57). Thus, the IL-4-deficient mice 
will prove  valuable for  elucidating the  molecular mecha- 
nisms of an  inappropriate immune response  to  a  parasite 
with fatal consequences for the host. 
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